Accolade Inc (ACCD)
47.18
+0.37 +0.79%
NASDAQ
Apr 9, 20:00
USD
Accolade Market Cap:
2.762B for April 9, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 2020.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| April 9, 2021 | 2.762B |
| April 8, 2021 | 2.740B |
| April 7, 2021 | 2.744B |
| April 6, 2021 | 2.853B |
| April 5, 2021 | 2.891B |
| April 1, 2021 | 2.743B |
| March 31, 2021 | 2.656B |
| March 30, 2021 | 2.603B |
| March 29, 2021 | 2.545B |
| March 26, 2021 | 2.448B |
| March 25, 2021 | 2.387B |
| March 24, 2021 | 2.231B |
| March 23, 2021 | 2.461B |
| March 22, 2021 | 2.516B |
| March 19, 2021 | 2.552B |
| March 18, 2021 | 2.656B |
| March 17, 2021 | 2.766B |
| March 16, 2021 | 2.706B |
| March 15, 2021 | 2.841B |
| March 12, 2021 | 2.694B |
| March 11, 2021 | 2.754B |
| March 10, 2021 | 2.525B |
| March 9, 2021 | 2.552B |
| March 8, 2021 | 2.307B |
| March 5, 2021 | 2.337B |
| March 4, 2021 | 2.287B |
| March 3, 2021 | 2.588B |
| March 2, 2021 | 2.583B |
| March 1, 2021 | 2.612B |
| Feb. 26, 2021 | 2.459B |
| Feb. 25, 2021 | 2.430B |
| Feb. 24, 2021 | 2.560B |
| Feb. 23, 2021 | 2.510B |
| Feb. 22, 2021 | 2.772B |
| Feb. 19, 2021 | 2.934B |
| Feb. 18, 2021 | 2.896B |
| Feb. 17, 2021 | 2.885B |
| Feb. 16, 2021 | 2.983B |
| Feb. 12, 2021 | 2.928B |
| Feb. 11, 2021 | 2.886B |
| Feb. 10, 2021 | 2.905B |
| Feb. 9, 2021 | 3.103B |
| Feb. 8, 2021 | 3.026B |
| Feb. 5, 2021 | 2.957B |
| Feb. 4, 2021 | 2.945B |
| Feb. 3, 2021 | 2.981B |
| Feb. 2, 2021 | 2.970B |
| Feb. 1, 2021 | 2.836B |
| Jan. 29, 2021 | 2.804B |
| Jan. 28, 2021 | 2.839B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| Cerner Corp | 22.00B |
| HealthStream Inc | 698.26M |
| HealthEquity Inc | 5.756B |
Market Cap Range, Past 5 Years
| Minimum | 1.404B | Jul 02 2020 |
| Maximum | 3.295B | Dec 10 2020 |
| Average | 2.276B |
Market Cap Related Metrics
| PS Ratio | 12.58 |
| PEG Ratio | -0.0148 |
| Price to Book Value | 7.114 |
| Price | 47.18 |
| Earnings Yield | -17.08% |
| PEGY Ratio | -0.0148 |
News
Analyst Actions: Morgan Stanley Adjusts Accolade's Price Target to $60 from $57, Keeps Overweight Rating
MT Newswires 04/06 11:32 ET
MT Newswires 04/06 11:32 ET
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
Globe Newswire 03/25 04:29 ET
Globe Newswire 03/25 04:29 ET
Accolade Announces Preliminary Results for Fourth Quarter and Full Year of Fiscal Year 2021
Globe Newswire 03/23 16:03 ET
Globe Newswire 03/23 16:03 ET
Analyst Actions: Canaccord Genuity Adjusts Accolade's Price Target to $62 From $59, Maintains Buy Rating
MT Newswires 03/18 10:33 ET
MT Newswires 03/18 10:33 ET
Analyst Actions: Goldman Sachs Reinstates Accolade at Buy With $59 Price Target
MT Newswires 03/11 08:33 ET
MT Newswires 03/11 08:33 ET
--Analyst Actions: Piper Sandler Adjusts Price Target on Accolade to $60 From $57, Maintains Overweight Rating
MT Newswires 02/16 10:31 ET
MT Newswires 02/16 10:31 ET
New Independent Study Finds Accolade Significantly Bends the Healthcare Cost Curve for Employer
PR Newswire 02/04 09:00 ET
PR Newswire 02/04 09:00 ET
Here's Why We're Not Too Worried About Accolade's (NASDAQ:ACCD) Cash Burn Situation
Yahoo 01/31 23:18 ET
Yahoo 01/31 23:18 ET
--Analyst Actions: Credit Suisse Adjusts Accolade's Price Target to $65 from $60, Keeps Outperform Rating
MT Newswires 01/28 09:27 ET
MT Newswires 01/28 09:27 ET
Advertisement
